-
Mechanisms of Cancer and Treatment-related Symptoms and Toxicities (R21)
(PA-16-258)
National Cancer Institute
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Inclusion of Mobile/e-Consents for Alzheimer's Disease Research (Admin Supp)
(PA-16-259)
National Institute on Aging
Application Receipt Date(s): August 15, 2016, by 5:00 PM local time of applicant organization.
-
Environmental Exposures and Health: Exploration of Non-Traditional Settings (R01)
(PA-16-263)
National Institute of Nursing Research
National Institute of Environmental Health Sciences
Application Receipt Date(s): Standard AIDS dates apply, by 5:00 PM local time of applicant organization. All types of AIDS and AIDS-related applications allowed for this funding opportunity announcement are due on these dates.
-
Environmental Exposures and Health: Exploration of Non-Traditional Settings (R21)
(PA-16-273)
National Institute of Nursing Research
National Institute of Environmental Health Sciences
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. The first standard application due date for this FOA is October 16, 2016.
-
Methodology and Measurement in the Behavioral and Social Sciences (R01)
(PAR-16-260)
Office of Behavioral and Social Sciences Research
National Institute on Alcohol Abuse and Alcoholism
National Institute on Aging
National Cancer Institute
National Institute on Deafness and Other Communication Disorders
National Eye Institute
National Institute of Neurological Disorders and Stroke
National Center for Complementary and Integrative Health
Office of Research on Women's Health
Office of Disease Prevention
Application Receipt Date(s): Standard AIDS dates apply, by 5:00 PM local time of applicant organization. All types of AIDS and AIDS-related applications allowed for this funding opportunity announcement are due on these dates. The first AIDS application due date for this FOA is January 7, 2017.
-
Methodology and Measurement in the Behavioral and Social Sciences (R21)
(PAR-16-261)
Office of Behavioral and Social Sciences Research
National Institute on Alcohol Abuse and Alcoholism
National Cancer Institute
National Institute on Deafness and Other Communication Disorders
National Eye Institute
National Institute of Neurological Disorders and Stroke
National Center for Complementary and Integrative Health
Office of Research on Women's Health
Office of Disease Prevention
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. The first standard application due date for this FOA is October 16, 2016.
-
Sustained Release of Antivirals for Treatment or Prevention of HIV (SRATP) (R01)
(PAR-16-262)
National Institute of Allergy and Infectious Diseases
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute of Mental Health
Application Receipt Date(s): January 4, 2017; January 4, 2018; January 4, 2019, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates.
-
Reducing the Duration of Untreated Psychosis in the United States (R34)
(PAR-16-264)
National Institute of Mental Health
Application Receipt Date(s): July 19, 2016; November 18, 2016; March 17, 2017; July 18, 2017; November 17, 2017; March 19, 2018; July 18, 2018; November 19, 2018; March 19, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Reducing the Duration of Untreated Psychosis in the United States (R01)
(PAR-16-265)
National Institute of Mental Health
Application Receipt Date(s): July 19, 2016; November 18, 2016; March 17, 2017; July 18, 2017; November 17, 2017; March 19, 2018; July 18, 2018; November 19, 2018; March 19, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (R01)
(PAR-16-266)
National Institute of Mental Health
National Institute on Alcohol Abuse and Alcoholism
National Institute on Aging
National Institute on Drug Abuse
National Institute of Biomedical Imaging and Bioengineering
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
NHLBI Career Transition Award for Intramural Fellows (K22)
(PAR-16-267)
National Heart, Lung, and Blood Institute
Application Receipt Date(s): July 20, 2016; thereafter standard dates apply , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Limited Competition: Small Grant Program for NIAMS K08 and K23 Recipients (R03)
(PAR-16-268)
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Application Receipt Date(s): October 19, 2016; February 20, 2017; October 19, 2017; February 19, 2018; October 19, 2018; February 19, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
NIAID Clinical Trial Implementation Grant (R01)
(PAR-16-269)
National Institute of Allergy and Infectious Diseases
Application Receipt Date(s): September 13, 2016; January 13, 2017; May 12, 2017; September 13, 2017 January 12, 2018 by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
NIAID Clinical Trial Implementation Cooperative Agreement (U01)
(PAR-16-270)
National Institute of Allergy and Infectious Diseases
Application Receipt Date(s): September 13, 2016; January 13, 2017; May 12, 2017; September 13, 2017 January 12, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
NIAID SBIR Phase II Clinical Trial Implementation Cooperative Agreement (U44)
(PAR-16-271)
National Institute of Allergy and Infectious Diseases
Application Receipt Date(s): September 13, 2016; January 13, 2017; May 12, 2017; September 13, 2017 January 12, 2018, by 5:00 PM local time of applicant organization.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
NIAID Clinical Trial Planning Grant (R34)
(PAR-16-272)
National Institute of Allergy and Infectious Diseases
Application Receipt Date(s): September 13, 2016; January 13, 2017; May 12, 2017; September 13, 2017 January 12, 2018; May 14, 2018; September 13, 2018; January 14, 2019; May 13, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Serious Adverse Drug Reaction Research (R21)
(PAR-16-274)
National Human Genome Research Institute
National Institute of Allergy and Infectious Diseases
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Cancer Institute
National Institute of Neurological Disorders and Stroke
National Institute on Minority Health and Health Disparities
Application Receipt Date(s): October 4, 2016; February 1, 2017; June 1, 2017; October 2, 2017; February 1, 2018; June 1, 2018; October 1, 2018; February 1, 2019; June 3, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Serious Adverse Drug Reaction Research (R01)
(PAR-16-275)
National Human Genome Research Institute
National Institute of Allergy and Infectious Diseases
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Cancer Institute
National Institute of Neurological Disorders and Stroke
National Institute on Minority Health and Health Disparities
Application Receipt Date(s): Standard AIDS dates apply by 5:00 PM local time of applicant organization. All types of AIDS and AIDS-related applications allowed for this funding opportunity announcement are due on these dates.
-
Partnerships for Structure-Based Design of Novel Immunogens for Vaccine Development (R01)
(RFA-AI-16-047)
National Institute of Allergy and Infectious Diseases
Application Receipt Date(s): October 3, 2016, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
-
BD2K Open Educational Resources for Skills Development in Biomedical Big Data Science (R25)
(RFA-HG-16-016)
National Human Genome Research Institute
National Institute on Aging
National Institute of Allergy and Infectious Diseases
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Cancer Institute
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Institute of Dental and Craniofacial Research
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Environmental Health Sciences
National Eye Institute
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Library of Medicine
National Institute of Mental Health
National Institute of Nursing Research
National Institute of Neurological Disorders and Stroke
National Center for Advancing Translational Sciences
John E. Fogarty International Center
National Institute of Biomedical Imaging and Bioengineering
Office of Research on Women's Health
Office of Behavioral and Social Sciences Research
Office of Disease Prevention
Office of Strategic Coordination (Common Fund)
National Center for Advancing Translational Sciences
Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
Application Receipt Date(s): August 2, 2016, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates.